期刊文献+

免疫性血小板输注无效的诊断及防治 被引量:3

原文传递
导出
摘要 血小板输注无效是指患者在输注血小板后,其血小板计数未见有效提升,临床出血症状未见改善。目前,临床判断血小板输注无效的主要依据为输注前、输注后1 h、输注后24 h时患者的血小板计数。
作者 穆士杰 陈扬
出处 《诊断学理论与实践》 2015年第6期494-498,共5页 Journal of Diagnostics Concepts & Practice
  • 相关文献

参考文献21

  • 1Holbro A, Infanti L, Sigle J, et al. Platelet transfusion: basic aspects[J]. Swiss Med Wkly,2013,143:w13885.
  • 2尤建国,李玉峰,汪承亚.血小板输注无效及干预措施的研究进展[J].国际输血及血液学杂志,2006,29(6):499-502. 被引量:28
  • 3杨眉,罗洪,舒彬,安邦权,夏世勤,王茂玲.1786例血小板输注的疗效分析[J].中国实验血液学杂志,2013,21(4):1038-1041. 被引量:21
  • 4伍伟健,卢瑾.同种免疫性抗体致血小板输注无效输血策略的国内外研究进展[J].中国免疫学杂志,2014,30(3):426-429. 被引量:32
  • 5Bub CB, Martinelli BM, Avelino TM, et al. Platelet antibody detection by flow cytometry: an effective method to evaluate and give transfusional support in platelet refractoriness[J]. Rev Bras Hematol Hemoter,2013;35(4):252-255.
  • 6Sareban N, Macher S, Drexler C, et al. Platelet antibody analysis by three different tests[J]. J Clin Lab Anal,2015,29(3): 198-202.
  • 7Hayashi T, Amakishi E, Matsuyama N, et al. Detection of anti-human platelet antibodies against integrin a2131 using cell lines[J]. Blood Transfus,2014,12(Suppl 1):s273- s280.
  • 8Chong W, Turro E, Metcalfe P, et al. A multicenter validation of recombinant β3 integrin-coupled beads to detect human platelet antigen-1 alloantibodies in 498 cases of fetomaternal alloimmune thrombocytopenia[J]. Transfu- sion,2015,55(11):2742-2751.
  • 9谢冲,王国民.Luminex液相芯片的发展及应用[J].复旦学报(医学版),2010,37(2):241-244. 被引量:33
  • 10Rockenbauer L, Eichelberger B, Panzer S. Comparison of the bead-based simultaneous analysis of specific platelet antibodies assay (SASPA) and Pak Lx Luminex technology with the monoclonal antibody immobilization of platelet antigens assay (MAIPA) to detect platelet alloantibodies[J]. Clin Chem Lab Med,2015,53(11):1779-1783.

二级参考文献88

  • 1邹元国,周晓政.改性玻纤膜白细胞过滤器的应用研究[J].南京军医学院学报,2003,25(4):229-231. 被引量:2
  • 2尤建国,李玉峰,汪承亚.血小板输注无效及干预措施的研究进展[J].国际输血及血液学杂志,2006,29(6):499-502. 被引量:28
  • 3黎劲.去白细胞输血的临床应用[J].右江民族医学院学报,2007,29(1):97-98. 被引量:3
  • 4孙先玲,兰炯采,吕运来,徐继,汪传喜,王军,郑舜琼,文国新,罗志,翟晓萍.血小板输注无效与对策[J].临床输血与检验,2007,9(1):88-90. 被引量:10
  • 5van Marwijk Kooy M, van Prooijen HC, Moes M, et al. Use of leukocyte-depleted platelet concentrates for the prevention of refractoriness and primary HLA alloimmunization: a prospective, randomized trial [ J]. Blood, 1991, 77 ( 1 ) : 201-205.
  • 6Oksanen K, Kekomaki R, Ruutu T, et al. Prevention of alloimmunization in patients with acute leukemia by use of white cell-reduced blood components- a randomized trial [ J ]. Transfusion, 1991, 31 (7) :588-594.
  • 7Williamson LM, Wimperis JZ, Williamson P, et al. Bedside filtration of blood products in the prevention of HLA alloim- munization-a prospective randomized study [ J ]. Alloimmunisation Study Group. Blood, 1994, 83(10):3028-3035.
  • 8Sintnicolaas K, van Marwijk Kooij M, van Prooijen HC, et al. Leukocyte depletion of random single-donor platelet transfusions does not prevent secondary human leukocyte antigen-alloimmunization and refractoriness: a randomized prospective study [ J]. Blood, 1995, 85 (3) :824-828.
  • 9The Trial to Reduce Alloimmunization to Platelets Study Group. Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions [ J]. N Engl J Med, 1997, 337 (26) : 1861-1569.
  • 10Seftel MD, Growe GH, Petraszko T, et al. Universal prestorage leukoreduction in Canada decreases platelet alloimmunization and refractoriness [ J ]. Blood, 2004, 103 ( 1 ) :333-339.

共引文献123

同被引文献24

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部